Expression of Angiotensin II Types 1 and 2 Receptors in Endometriotic Lesions

Takehiro Nakao1, Fumihisa Chishima, Masahiko Sugitani

  • 1Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo, Japan.

Abstract

Insights

The renin-angiotensin system, involving angiotensin type 1 (AT1) and AT2 receptors, is implicated in endometriosis. Increased AT1/AT2 ratios and links to prostaglandin synthases were found in endometriotic lesions.

Area of Science:

  • Reproductive biology
  • Endocrinology
  • Molecular medicine

Background:

  • Endometriosis is a complex gynecological condition.
  • The renin-angiotensin system (RAS) and prostaglandin synthases are implicated in its pathophysiology.
  • Understanding receptor expression in endometriosis is crucial.

Purpose of the Study:

  • To investigate the gene and protein expression of angiotensin type 1 (AT1) and AT2 receptors in endometriotic lesions.
  • To explore the relationship between AT1/AT2 receptor expression and prostaglandin (PG) synthases in endometriosis.
  • To elucidate the role of RAS in the pathophysiology of endometriosis.

Main Methods:

  • Analysis of endometriotic cysts (n=32) and eutopic endometrium samples.
  • Quantitative RT-PCR to assess mRNA expression of AT1, AT2 receptors, and PG synthases (PG-endoperoxide synthase 2, mPGES-1).
  • Immunohistochemical staining for AT1 and AT2 receptor proteins.

Main Results:

  • AT1 and AT2 receptor proteins were localized in endometrial glandular epithelium and stromal cells.
  • Significantly higher AT1/AT2 receptor ratio in endometriotic cysts compared to eutopic endometrium (p < 0.001).
  • Correlation observed between AT1 mRNA and mPGES-1 mRNA in endometriotic cysts, and AT2 mRNA and mPGES-1 mRNA in eutopic endometrium.

Conclusions:

  • The renin-angiotensin system plays a significant role in endometriosis.
  • Altered AT1/AT2 receptor expression and its association with prostaglandin synthases suggest a potential therapeutic target.
  • Further research into RAS modulation for endometriosis treatment is warranted.

Related Concept Videos

Adrenergic Receptors: &#593; Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.2K
Adrenergic Receptors: &#946; Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.3K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.7K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K